Evidence map›Paper›PMID 26068089›Full record

ArticleInternational journal of environmental research and public health2015

Why Don't Smokers Want Help to Quit? A Qualitative Study of Smokers' Attitudes towards Assisted vs. Unassisted Quitting.

Kylie Morphett, Brad Partridge, Coral Gartner, Adrian Carter, Wayne Hall

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  2. Recommendations on interventions for tobacco smoking cessation in adults in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  3. Pooled it
  4. Interventions to increase adherence to medications for tobacco dependence.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Trial
  6. Can We Predict Who Will Experience Adverse Events While Using Smoking Cessation Pharmacotherapy? A Secondary Analysis of the EAGLES Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  7. Withdrawal Symptom, Treatment Mechanism, and/or Side Effect? Developing an Explicit Measurement Model for Smoking Cessation Research.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Natural Trajectory of Smoking Cessation Among Cancer Patients Who Want to Quit "On Their Own": A Mixed-Methods, Longitudinal Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kylie MorphettUniversity of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Site, Herston, 4029 Queensland, Australia. k.morphett@uq.edu.au.
Brad PartridgeUniversity of Queensland Centre for Youth Substance Abuse, Mental Health Centre, Royal Brisbane and Women's Hospital, Herston, 4029 Queensland, Australia. bradparto@hotmail.com.
Coral GartnerUniversity of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Site, Herston, 4029 Queensland, Australia. c.gartner@uq.edu.au.
Adrian CarterUniversity of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Site, Herston, 4029 Queensland, Australia. adrian.carter@monash.edu.
Wayne HallUniversity of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Site, Herston, 4029 Queensland, Australia. bradparto@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of prescription medication for smoking cessation and the introduction of evidence-based guidelines for health professionals has increasingly medicalised smoking cessation. There are debates about whether medicalisation is a positive development, or whether it has devalued unassisted quitting. In this debate the views of smokers have been neglected. This study explored the attitudes of smokers towards a range of quitting methods, and their considerations when judging their value. We conducted semi-structured interviews with 29 smokers and analysed data using thematic analysis. The results show that the perceived nature of an individual smoker's addiction was central to judgments about the value of pharmacological cessation aids, as was personal experience with a method, and how well it was judged to align with an individual's situation and personality. Unassisted quitting was often described as the best method. Negative views of pharmacological cessation aids were frequently expressed, particularly concerns about side effects from prescription medications. Smokers' views about the value of different methods were not independent: attitudes about cessation aids were shaped by positive attitudes towards unassisted quitting. Examining smokers' attitudes towards either assisted or unassisted quitting in isolation provides incomplete information on quitting preferences.

Indexed as

Attitude to HealthAdolescentAdultAgedAustraliaFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPerceptionSmoking CessationYoung Adultattitudemedicalizationqualitative researchsmokingsmoking cessation

Identifiers

PMID26068089
PMCPMC4483718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.